The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
To effectively respond to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an increasing number of researchers are focusing on the antiviral activity of cepharanthine (CEP), which is a clinically approved drug being used for over 70 years. This review aims to provide a brief overview of...
Saved in:
Main Authors: | Binbin Xia (Author), Li Zheng (Author), Yali Li (Author), Wenfang Sun (Author), Yang Liu (Author), Liushui Li (Author), Jingyao Pang (Author), Jing Chen (Author), Jiaxin Li (Author), Hua Cheng (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19
by: Ping Jiang, et al.
Published: (2022) -
Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
by: Wenfang Sun, et al.
Published: (2024) -
Determination of cepharanthine in rat plasma by LC-MS/MS and its application to a pharmacokinetic study
by: Yingbin Deng, et al.
Published: (2017) -
Constructive strategies for drug delivery systems in antivirus disease therapy by biosafety materials
by: Li Wang, et al.
Published: (2022) -
Antivirus effectiveness of ivermectin on dengue virus type 2 in Aedes albopictus.
by: Tie-Long Xu, et al.
Published: (2018)